MetaADEDB 2.0 @ LMMD
azasetron
(WUKZPHOXUVCQOR-UHFFFAOYSA-N)
Structure
SMILES
Clc1cc2N(C)C(=O)COc2c(c1)C(=O)NC1CN2CCC1CC2
Molecular Formula:
C17H20ClN3O3
Molecular Weight:
349.812
Log P:
1.9130
Hydrogen Bond Acceptor:
6
Hydrogen Bond Donor:
1
TPSA:
61.88
CAS Number(s):
123039-99-6; 123040-69-7
Synonym(s)
1.
azasetron
2.
N-(1-azabicyclo(2.2.2)oct-3-yl)-6-chloro-4-methyl-3-oxo-3,4 -dihydro-2H-1,4-benzoxazine-8-carboxamide hydrochloride
3.
Y 25130
4.
Y-25130
5.
azasetron, (+-)-isomer
External Link(s)
MeSHC070671
PubChem Compound2264
ChEBI91712
CHEMBLCHEMBL1598608
DrugCentral267
IUPHAR/BPS Guide to PHARMACOLOGY2285
KEGGdr:D07481
Therapeutic Target DatabaseD00SVU
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1AcidosisOFFSIDES
2Acute respiratory failureOFFSIDES
3Alanine Aminotransferase IncreasedOFFSIDES
4Antithrombin III decreasedOFFSIDES
5AnuriaOFFSIDES
6ApathyOFFSIDES
7AphagiaOFFSIDES
8Atrial thrombosisOFFSIDES
9Blood GlucoseOFFSIDES
10Blood alkaline phosphatase increasedOFFSIDES
11Blood creatinine decreasedOFFSIDES
12Blood creatinine increasedOFFSIDES
13Blood fibrinogenOFFSIDES
14Blood lactate dehydrogenase increasedOFFSIDES
15Blood phosphorus increasedOFFSIDES
16Blood potassium increasedOFFSIDES
17Bone marrow depressionOFFSIDES
18Bulbar palsyOFFSIDES
19Candida sepsisOFFSIDES
20Cerebellar AtaxiaOFFSIDES
21Choking sensationOFFSIDES
22CholangiolitisOFFSIDES
23Coagulation test abnormalOFFSIDES
24Cold sweatOFFSIDES
25CyanosisOFFSIDES
26Depressed Level of ConsciousnessOFFSIDES
27Disseminated Intravascular CoagulationOFFSIDES
28Duodenal UlcerOFFSIDES
29Ejection Fraction DecreasedOFFSIDES
30Engraft failureOFFSIDES
31ErythropeniaOFFSIDES
32Escherichia infectionOFFSIDES
33Feeling abnormalOFFSIDES
34Gamma-Glutamyltransferase IncreasedOFFSIDES
35Gastrointestinal perforationOFFSIDES
36Glomerular vascular disorderOFFSIDES
37Hepatic congestionOFFSIDES
38Metastases to abdominal cavityOFFSIDES
39MoaningOFFSIDES
40Neutrophil count decreasedOFFSIDES
41OliguriaOFFSIDES
42Pancreatic NeoplasmOFFSIDES
43PeriodontitisOFFSIDES
44PeritonitisOFFSIDES
45PolymyositisOFFSIDES
46Procedural site reactionOFFSIDES
47Prothrombin time ratioOFFSIDES
48PurulenceOFFSIDES
49PyelonephritisOFFSIDES
50Radiation PneumonitisOFFSIDES
51Renal tubular necrosisOFFSIDES
52RhabdomyolysisOFFSIDES
53Skin ErosionOFFSIDES
54Splenic abscessOFFSIDES
55Thrombosis in deviceOFFSIDES
56Ventricular FibrillationOFFSIDES
57Wound decompositionOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120238

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.